|1.||Kano, R: 2 articles (04/2003 - 01/2002)|
|2.||Hanahachi, A: 2 articles (04/2003 - 01/2002)|
|3.||Hasegawa, A: 2 articles (04/2003 - 01/2002)|
|4.||van der Meijden, Paola E J: 1 article (09/2015)|
|5.||Crijns, Harry: 1 article (09/2015)|
|6.||Heemskerk, Johan W M: 1 article (09/2015)|
|7.||Baaten, Constance C F M J: 1 article (09/2015)|
|8.||Wetzels, Rick: 1 article (09/2015)|
|9.||Swieringa, Frauke: 1 article (09/2015)|
|10.||Henskens, Yvonne M C: 1 article (09/2015)|
09/01/1997 - "Numerous clinical studies have observed a correlation between thiazole orange-positive platelets and platelet synthesis, thereby providing a noninvasive means to differentiate between synthetic and destructive mechanisms in thrombocytopenia. "
11/01/2000 - "Reticulated platelet (RP) analysis using thiazole orange (TO) and a flow cytometer is a convenient and promising method for estimating platelet kinetics in patients with thrombocytopenia. "
04/19/2003 - "Thiazole orange-positive platelets in cats with thrombocytopenia induced by cyclophosphamide."
03/01/1992 - "We analyzed the RNA in platelets by fluorescence flow cytometry after staining with thiazole orange(TO) in whole blood samples from hematologically normal subjects and patients with thrombocytopenia. "
06/01/1993 - "We used thiazole orange fluorescence labeling to determine the percentage of circulating reticulated platelets and two antibodies with different specificities directed against human IgG to measure platelet-associated IgG by flow cytometry in 59 patients with either immune thrombocytopenic purpura (n = 23) or chemotherapy-induced thrombocytopenia (n = 36). "
01/15/2009 - "Thiazole Orange derivatives: synthesis, fluorescence properties, and labeling cancer cells."
11/01/2012 - "In the present study, we developed a novel folic acid (FA) conjugated chitosan (CTS) grafted thiazole orange (TO) complex (FA-CTS-TO), and the formation can be used to label tumor cells. "
|3.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/01/2004 - "Whole blood flow cytometry using thiazole orange was performed to compare the % RP in patients in the early (1-27 d, n = 79) and late phases (79-725 d, n = 70) after ischaemic stroke or transient ischaemic attack (TIA) with controls without CVD (n = 27). "
05/15/2002 - "We measured %RP by flow cytometry using the fluorescent dye thiazole orange (TO) to evaluate platelet kinetics in patients with different clinical categories of ischemic stroke. "
|5.||Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/12/2002 - "Thiazole orange-positive platelets in a dog with idiopathic thrombocytopenic purpura."
07/01/2007 - "We used a whole blood flow cytometry method combining thiazole orange and anti-CD41a-staining to assess RP in 71 healthy subjects, six with thrombocytopenic myelodysplastic syndrome (MDS), nine with liver cirrhosis, 14 patients with idiopathic thrombocytopenic purpura (ITP), and 12 patients who had undergone hematopoietic stem cell transplantation (HSCT). "
|1.||Folic Acid (Vitamin M)
|3.||Messenger RNA (mRNA)
|4.||RNA (Ribonucleic Acid)
|6.||Inosine Triphosphate (ITP)
|7.||Immunoglobulin G (IgG)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|2.||Hematopoietic Stem Cell Transplantation
|3.||Drug Therapy (Chemotherapy)